Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

RENE.L (RENE) Share News

12345678

ReNeuron Says Stroke Disability Therapy Study Yielding "Encouraging" Results

7th May 2014 14:15

LONDON (Alliance News) - Stem cell therapy company ReNeuron Group PLC Wednesday said that its PISCES study of its ReN001 stem cell therapy for stroke disability has continued to yield encouraging results. The company said that there was no cell-related or immunological adverse events report Read More

ReNeuron Seeking New Chief Executive, Current To Become Financial Officer

23rd Apr 2014 11:37

LONDON (Alliance News) - ReNeuron Group PLC said Wednesday that it was appointing a new Chief Executive Officer to replace Michael Hunt, who will be moving into the role of Chief Financial Officer when a successor has been recruited. The company said that, as a result of the progress it has Read More

ReNeuron Leases New Research & Development Facility With Welsh Government

15th Apr 2014 10:01

LONDON (Alliance News) - Stem cell therapy company ReNeuron Group PLC said Tuesday that it had signed an agreement with the Welsh Government to lease a new research and development facility at the Pencoed Technology Park near Cardiff, South Wales. ReNeuron expects to begin to relocate its o Read More

UK MORNING BRIEFING: Aggreko Leads After Mixed Results

15th Apr 2014 07:50

LONDON (Alliance News) - Aggreko is leading the FTSE 100 in early trading Tuesday after the temporary power company said it has seen mixed results in its first quarter, with strong underlying revenue growth in two of its three regions being impacted by adverse currency movements as previously exp Read More

UK MIDDAY BRIEFING: Regulators Confirm UK Energy Market Review

27th Mar 2014 13:48

LONDON (Alliance News) - UK regulators have now confirmed they will investigate whether the country's major energy companies are preventing effective competition in the market, a decision that prompted British Gas parent Centrica to warn that the review could delay crucial investments in new i Read More

UK WINNERS & LOSERS: Babcock, Tullow Oil Lead Blue-Chip Fallers

27th Mar 2014 13:01

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.<br /><br />-------<br /><br /><strong>FTSE 100 - WINNERS</strong><br /><br /><strong>Old Mutual</strong>, up 0.5%. The group has agreed to sell Skandia Germany and S Read More

ReNeuron Gets Approvals To Begin Two New Trials Using Stem Cell Product

27th Mar 2014 11:13

LONDON (Alliance News) - ReNeuron Group PLC said Thursday that it has received final regulatory and ethical approvals to begin two new clinical trials using its CTXcyro stem cell product. The company will begin a Phase II clinical trial of its ReN001 investigational therapy in stroke disabi Read More

ReNeuron Eyes New UK Government Scheme Encouraging Novel Therapies

14th Mar 2014 13:04

LONDON (Alliance News) - ReNeuron Group PLC Friday said it will look at whether the UK government's plan to launch a scheme to encourage the take up of novel therapies could be applied to its own therapeutic candidates. The scheme, called the Early Access to Medicines Scheme, is looking to Read More

ReNeuron Retinal Stem Cell System Wins FFB Support

11th Mar 2014 11:27

LONDON (Alliance News) - ReNeuron Group PLC said Tuesday its retinal stem cell therapy candidate is to receive support from a retinal research funding foundation. ReNeuron said its ReN003 retinal stem cell therapy candidate for the treatment of retinis pigmentosa is set to receive support Read More

ReNeuron Sees Positive Data For Stem Cells In Retinal Degeneration Test

21st Jan 2014 10:04

LONDON (Alliance News) - ReNeuron Group PLC said Tuesday that a paper detailing the efficiency of its human retinal stem cells in a test model of retinal degeneration had been published in the Journal of Biological Chemistry. The test showed that ReNeuron's cells protected visual function w Read More

UK MORNING BRIEFING: Shares Higher; Unilever, SABMiller As Expected

21st Jan 2014 08:19

LONDON (Alliance News) - UK shares have opened higher Tuesday, as <strong>Unilever</strong> and<strong> SABMiller</strong> have released results and trading statements in line with expectations. <br /><br />Peel Hunt has issued ratings on the property sector, cutting <strong>Great Portland Est Read More

ReNeuron Moving All Therapeutic Programmes To Phase II Trials In Next 3 Years

13th Sep 2013 09:02

Read More

12345678
FTSE 100 Latest
Value8,809.74
Change53.53